Press release
What's driving the Human Immunodeficiency Virus (HIV) Drugs Market Size ? AbbVie, Merck, Gilead Sciences, Bristol Myers Squibb, Janssen (Johnson&Johnson), GlaxoSmithKline (GSK)
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1629933/?utm_source=openpr.com&utm_medium=Deepak
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscape, and discusses major trends. The report offers the most up-to-date industry data on the actual market situation, and future outlook for global human immunodeficiency virus (HIV) drugs market. The report includes historical data from 2015 to 2018, and forecasts until 2025.
The Major Companies Dominating this Market for its Drugs, Services and Continuous Drugs Developments are:
AbbVie
Merck
Gilead Sciences
Bristol Myers Squibb
Janssen (Johnson&Johnson)
GlaxoSmithKline (GSK)
The report contains a granular analysis of the present industry situations, market demands, reveals facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global human immunodeficiency virus (HIV) drugs market. The report explores detailed analysis of top 22 HIV drugs market assessment globally from 2015 to 2018 and forecasts to 2025. The report also details the latest happenings about the global research & development of HIV drugs.
Additionally, the report includes an assessment of clinical trials and promising human immunodeficiency virus (HIV) drugs in clinical development. Key trends in terms of collaboration, partnerships, and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the global human immunodeficiency virus (HIV) drugs market.
The report concludes with the profiles of major players in the global human immunodeficiency virus (HIV) drugs market. The key market players are evaluated on various parameters such as business overview and recent development.
Top 22 Human Immunodeficiency Virus (HIV) Drugs Covered Under this Report are:
Tivicay
Triumeq
Juluca
Epzicom
Selzentry
Kaletra
Sustiva
Reyataz
Atripla
Truvada
Viread
Complera
Stribild
Genvoya
Biktarvy
Descovy
Odefsey
Prezista/Prezcobix
Edurant
Isentress
Pifeltro
Delstrigo
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1629933/?utm_source=openpr.com&utm_medium=Deepak
The Latest Industry Data Included in this Report:
Global HIV Drugs Market Size & Analysis (2015 2025)
Global HIV Drugs Market Share & Y-o-Y Growth (%),2015 2025
Global Top 22 HIV Drugs Market Assessment & Opportunity (2015 2025)
Promising HIV Drugs in Clinical Development
HIV Drugs Clinical Trial Insight by Phase, Institute & Country,2018
Major Deals (Key Agreements, Partnerships & Collaborations)
Latest Happenings in Global HIV Drugs Market
Key Drivers & Inhibitors of the Global HIV Drugs Market
Major Companies Analysis
The Answers to the Following Key Questions can be found in the Report:
What is the size of the global HIV drugs market during 2015 -2025
What will be the revenue generated by each drug during the forecast period
Which major drug provides the highest market share
How are the overall market and major drugs growing
What are the key drivers and inhibitors in the current market
What will be the impact of drivers and inhibitors in the future
How is the market predicted to develop in the future
Who are the key players in this market space
1. Executive Summary
2. Global HIV Drugs Market Size & Analysis (2015 2025)
3. Global HIV Drugs Market Share & Y-o-Y Growth (%),2015 2025
4. Latest Happenings in Global HIV Drugs Market
5. Key Drivers & Inhibitors of the Global HIV Drugs Market
5.1 Market Drivers
5.2 Inhibitors
6. Global Top 22 HIV Drugs Market Assessment & Opportunity (2015 2025)
6.1 Tivicay (dolutegravir)
6.2 Triumeq (dolutegravir/abacavir/lamivudine)
6.3 Juluca (dolutegravir and rilpivirine)
6.4 Epzicom (abacavir and lamivudine)
6.5 Selzentry (maraviroc)
6.6 Kaletra (Iopinavir/ritonavir)
6.7 Sustiva (efavirenz)
6.8 Reyataz (atazanavir)
6.9 Atripla (efavirenz/emtricitabine/tenofovir)
6.10 Truvada (emtricitabine/tenofovir disoproxil fumarate)
6.11 Viread (tenofovir disoproxil fumarate)
6.12 Complera (emtricitabine, rilpivirine, and tenofovir disoproxil fumarate)
6.13 Stribild (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate)
6.14 Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide)
6.15 Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide)
6.16 Descovy (emtricitabine and tenofovir alafenamide)
6.17 Odefsey (emtricitabine, rilpivirine, and tenofovir alafenamide)
6.18 Prezista/Prezcobix (darunavir ethanolate /cobicistat)
6.19 Edurant (rilpivirine)
6.20 Isentress (raltegravir)
6.21 Pifeltro (doravirine)
6.22 Delstrigo (doravirine / lamivudine / tenofovir disoproxil fumarate)
7. Partnerships, Collaboration & Licensing Agreement in Global HIV Drugs Market
8. Promising HIV Drugs in Clinical Development
9. HIV Drugs Clinical Trial Insight by Phase, Institute & Country,2018
10. Key Companies Analysis
10.1 AbbVie
10.1.1 Business Overview
10.1.2 Recent Development
10.2 GlaxoSmithKline (GSK)
10.2.1 Business Overview
10.2.2 Recent Development
10.3 Gilead Sciences
10.3.1 Business Overview
10.3.2 Recent Development
10.4 Merck
10.4.1 Business Overview
10.4.2 Recent Development
10.5 Bristol Myers Squibb
10.5.1 Business Overview
10.5.2 Recent Development
10.6 Janssen (Johnson & Johnson)
10.6.1 Business Overview
10.6.2 Recent Development
More Details on this Report: https://www.marketstudyreport.com/reports/global-human-immunodeficiency-virus-hiv-drugs-market-2019-2025-top-22-drugs-analysis-key-trends-players-and-forecasts/?utm_source=openpr.com&utm_medium=Deepak
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: www.marketstudyreport.com
Blog: www.marketstudyreport.com/blog
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What's driving the Human Immunodeficiency Virus (HIV) Drugs Market Size ? AbbVie, Merck, Gilead Sciences, Bristol Myers Squibb, Janssen (Johnson&Johnson), GlaxoSmithKline (GSK) here
News-ID: 1763078 • Views: …
More Releases from marketstudyreport.com
Load Bank Market Growth Prospectus by 2028 - Business Opportunities by ASCO Powe …
A concise assortment of data on the 'Load Bank Market' offers an exhaustive study targeting current market trends influencing the business across assorted regions. Significant details related to market size, market share, applications, and statistics are put together to convey an ensemble prediction of the industry. The research further focuses on comprehensive competitor analysis in addition to highlighting growth strategies embraced by market leaders.
Load Bank Market Size was estimated…
Agriculture Equipment Market is Expected to Reach USD 161640 Million by 2028 - J …
Global Agriculture Equipment Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of the market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report.
Global Agriculture Equipment Market Size was estimated at USD 114110 million in 2021 and is projected to reach USD 161640 million by 2028, exhibiting a CAGR of…
Electric Vehicle Market Size to grow at a CAGR of 23.5% through 2028| Tesla Inc. …
Global Electric Vehicle Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report.
The electric vehicles (EVs) market is estimated to witness a robust growth rate of 23.5% during the period 2019-2028.
The operation is done to stop ligament tears and…
Fuel Cell Air Compressor Market is Expected to Reach USD 512.3 Million by 2028 - …
Global Fuel Cell Air Compressor Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report.
Global Fuel Cell Air Compressor Market Size was estimated at USD 215.1 million in 2021 and is projected to reach USD 512.3 million by 2028, exhibiting…
More Releases for HIV
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus.
Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral…
